CLANCY PAUL J 1409601 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-12 | 2023-06-08 | 2023-06-08 | 4 | Clancy Paul J | DIRECTOR | acq | 3599.0 | 24.48 | 0.2 | 0.0 | Direct | Common Stock | EXACT SCIENCES CORP | code A | 14701.0 | 180.39 (EXAS) |
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Clancy Paul J | DIRECTOR | acq | 2505.0 | 17.63 | 0.11 | 0.0 | Direct | Common Stock | INCYTE CORP | code A | 14211.0 | 223.09 (INCY) |
| 2023-07-05 | 2023-06-30 | 2023-06-30 | 4 | Clancy Paul J | DIRECTOR | acq | 380.0 | 2.6 | 0.02 | 62.25 | Direct | Common Stock | INCYTE CORP | code A | 14591.0 | 223.09 (INCY) |
| 2023-10-03 | 2023-09-29 | 2023-09-29 | 4 | Clancy Paul J | DIRECTOR | acq | 379.0 | 2.53 | 0.02 | 57.77 | Direct | Common Stock | INCYTE CORP | code A | 14970.0 | 224.09 (INCY) |
| 2024-01-03 | 2023-12-29 | 2023-12-29 | 4 | Clancy Paul J | DIRECTOR | acq | 412.0 | 2.68 | 0.02 | 62.79 | Direct | Common Stock | INCYTE CORP | code A | 15382.0 | 224.11 (INCY) |
| 2024-04-02 | 2024-03-28 | 2024-03-28 | 4 | Clancy Paul J | DIRECTOR | acq | 403.0 | 2.55 | 0.02 | 56.97 | Direct | Common Stock | INCYTE CORP | code A | 15785.0 | 224.53 (INCY) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-13 | 2023-06-12 | 2023-06-12 | 4 | Clancy Paul J | DIRECTOR | acq | 13200.0 | 100.0 | 4.81 | 2.8 | Direct | Stock Option (Right To Buy) | XILIO THERAPEUTICS, INC. | code A | 13200.0 | 27.47 (XLO) |
| 2023-06-16 | 2023-06-14 | 2023-06-14 | 4 | Clancy Paul J | DIRECTOR | acq | 11294.0 | 100.0 | 0.51 | 61.44 | Direct | Non Qualified Stock Option (Right To Buy) | INCYTE CORP | code A | 11294.0 | 223.09 (INCY) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)